Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymidine phosphorylase (TP), also known as TYMP, is an enzyme involved in nucleoside metabolism. It catalyzes the reversible phosphorolysis of thymidine to produce thymine and 2-deoxy-D-ribose-1-phosphate. This reaction is crucial for pyrimidine metabolism, regulation of nucleoside levels, angiogenesis, and maintenance of mitochondrial DNA. TP is overexpressed in various tumors where it contributes to angiogenesis, tumor growth, and metastasis. Deficiency in TYMP causes mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
Catalyzes the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose-1-phosphate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymidine Phosphorylase (TP).